Copyright
©The Author(s) 2025.
World J Transplant. Mar 18, 2025; 15(1): 93253
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.93253
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.93253
Immunosuppression class | Drugs/therapies | Mechanism of action |
Antimetabolites | Mycophenolate mofetil | Inhibition of de novo purine synthesis in lymphocytes |
Biologic agents | Polyclonal antibodies (ATGAM, Thymoglobulin) | Lysis of lymphocytes |
Calcineurin inhibitors | Cyclosporine A Tacrolimus | Inhibitors of an intracellular phosphate required for interleukin-2 production in the T lymphocytes |
Corticosteroids | Methylprednisolone; Prednisone | Regulators of gene expression |
Non-calcineurin inhibitors | Sirolimus; Everolimus | Inhibitors of mammalian target of target of rapamycin activation in lymphocytes, resulting in cycle cell arrest |
- Citation: Gadour E. Lesson learnt from 60 years of liver transplantation: Advancements, challenges, and future directions. World J Transplant 2025; 15(1): 93253
- URL: https://www.wjgnet.com/2220-3230/full/v15/i1/93253.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i1.93253